Dr. Reddy's Laboratories shares in Friday's trade slipped by over 6 per cent in early trade to the day's low price of Rs 1,203.6 after the pharma major posted weak performance during the December ...
Cyient is grappling with multiple challenges, including disappointing Q3 results, a downward revision in FY25 growth guidance, and the CEO's resignation, all of which have dampened investor sentiment.
We are bullish on Lynas despite recent underperformance, citing upcoming production increases and potential price benefits. Read more on LYSDY stock here.
On July 11, It Begins. Superman - Only in Theaters 2025. Traveling over our heads at hypersonic speeds beyond Mach 7, lies the future of spy plane technology. It can be anywhere in the world in one ...
Strong and unique passwords are your first line of defence against cyber threats. Find out how to make it manageable using a little effort and the right tools.
While National Insurance, United India Insurance and Oriental India Insurance are considered weak, market leader New India Assurance is seen as strong and not a candidate for privatization.
Efforts to conserve capital by suspending share buybacks in the initial stages of the pandemic paid off, and the company was able to navigate the uncertainty of 2020 and 2021 with ease. Discover is in ...
Icade offers a high-dividend yield and low valuation, but its weak fundamentals and challenging business prospects justify this profile. Learn more CDMGF stock here.
Romania's government is proposing a lower deficit than last year, but the market still have questions given May's presidential election. The finance ministry wants to focus on local funding sources ...